摘要
主动脉瓣置换术目前仍是重度主动脉瓣狭窄的标准治疗,但是有些高龄、全身状况差、合并症多的患者手术风险高,创伤大,术后死亡率高。经导管主动脉瓣植入术(Transcatheteraorticvalveimplantation,TAVI)近年来发展迅速,国外许多研究已经证实了其有效性,到目前为止,全球已经有10多万人接受了TAVI手术,在取得良好效果的同时也面临许多问题,并发症仍然较多。介入治疗经验的积累,瓣膜材料技术的进展将推进瓣膜疾病治疗的进展。
Aortic valve replacument remains the standand therapy for serious valve stenosis. But for many elderly patients with multiple complications and poor health,the operation is high in risks and mortality. Recently years,transcatheter aortic valve implantation TAVI has been rapidly developed. Up to now,more than 50 thousands of the patients has undergone the procedure in the world. TAVI demonstrated many problems as well as good cure results,which would be improved by intervention therapy,development of valve of materials.
出处
《外科研究与新技术》
2014年第2期88-91,共4页
Surgical Research and New Technique
关键词
主动脉瓣狭窄
经导管主动脉瓣置换术
Aortic valve stenrsis
Transcatheter aortic valve implantation
